In addition, intravenous administration of hUC-MSCs effectively downregulated the expression of pro-inflammatory cytokines, including IL-1β, TNF-α, matrix metalloproteinase 9, and IL-6, which are upregulated by ischemia [9]. The gene discussed is MMP9; the disease is ischemia.